Metlife Stock EBITDA

MET Stock

USD 86.44 1.25 1.47%

MetLife fundamentals help investors to digest information that contributes to MetLife's financial success or failures. It also enables traders to predict the movement of MetLife Stock. The fundamental analysis module provides a way to measure MetLife's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MetLife stock.

		Last Reported	Projected for Next Year
	EBITDA	3.9 B	5.4 B

EBITDA is likely to gain to about 5.4 B in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

MetLife Company EBITDA Analysis

MetLife's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current MetLife EBITDA

3.92 B

Most of MetLife's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MetLife is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

MetLife EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for MetLife is extremely important. It helps to project a fair market value of MetLife Stock properly, considering its historical fundamentals such as EBITDA. Since MetLife's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MetLife's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MetLife's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Short Term Investments	Treasury Stock	Intangible Assets	Common Stock	Property Plant Equipment	Deferred Long Term Liab	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Capital Stock	Current Deferred Revenue
Total Assets		0.82	0.4	0.51	1.0	0.24	-0.85	-0.3	0.1	0.73	0.89	0.7	0.16	0.4	0.62	0.06	0.63	0.51	-0.81	0.11	0.34	0.06	-0.15	0.23	0.17	0.11
Total Stockholder Equity	0.82		0.33	0.26	0.79	0.17	-0.58	-0.6	-0.19	0.37	0.67	0.61	0.28	0.13	0.34	0.13	0.85	0.83	-0.78	-0.1	0.62	0.11	-0.29	0.69	0.31	0.25
Net Debt	0.4	0.33		-0.31	0.4	0.33	-0.07	-0.44	0.3	0.26	0.41	-0.19	0.75	0.07	-0.18	-0.54	0.03	0.41	-0.3	-0.62	0.6	0.74	-0.69	0.29	0.31	0.61
Retained Earnings	0.51	0.26	-0.31		0.53	0.04	-0.66	0.17	0.31	0.5	0.57	0.56	-0.61	0.5	0.83	0.59	0.29	0.01	-0.26	0.71	-0.41	-0.5	0.63	-0.22	0.07	-0.62
Total Liab	1.0	0.79	0.4	0.53		0.24	-0.87	-0.26	0.13	0.76	0.89	0.7	0.14	0.42	0.64	0.05	0.59	0.46	-0.79	0.13	0.3	0.06	-0.13	0.17	0.15	0.09
Total Current Assets	0.24	0.17	0.33	0.04	0.24		-0.23	-0.31	0.53	0.17	0.43	-0.1	0.01	0.65	-0.01	0.26	-0.14	0.07	-0.17	-0.11	0.11	0.19	0.12	0.07	-0.02	-0.16
Short Term Debt	-0.85	-0.58	-0.07	-0.66	-0.87	-0.23		0.1	-0.18	-0.73	-0.87	-0.71	0.3	-0.41	-0.83	-0.3	-0.39	-0.09	0.8	-0.5	0.11	0.31	-0.25	0.16	0.16	0.2
Accounts Payable	-0.3	-0.6	-0.44	0.17	-0.26	-0.31	0.1		0.2	0.09	-0.39	-0.2	-0.39	0.02	0.05	-0.09	-0.49	-0.7	0.44	0.35	-0.58	-0.31	0.34	-0.7	-0.52	-0.37
Long Term Debt	0.1	-0.19	0.3	0.31	0.13	0.53	-0.18	0.2		0.29	0.35	-0.42	-0.25	0.56	0.2	0.1	-0.53	-0.32	0.11	0.19	-0.37	0.0	0.32	-0.41	-0.24	-0.38
Net Receivables	0.73	0.37	0.26	0.5	0.76	0.17	-0.73	0.09	0.29		0.69	0.45	0.0	0.4	0.76	0.08	0.19	0.06	-0.56	0.4	0.02	-0.1	0.09	-0.21	-0.16	0.0
Good Will	0.89	0.67	0.41	0.57	0.89	0.43	-0.87	-0.39	0.35	0.69		0.52	-0.05	0.49	0.71	0.26	0.36	0.33	-0.81	0.25	0.14	-0.09	0.07	0.07	0.13	-0.06
Short Term Investments	0.7	0.61	-0.19	0.56	0.7	-0.1	-0.71	-0.2	-0.42	0.45	0.52		-0.11	0.14	0.62	0.23	0.78	0.36	-0.57	0.33	0.08	-0.21	0.09	0.16	0.2	-0.08
Treasury Stock	0.16	0.28	0.75	-0.61	0.14	0.01	0.3	-0.39	-0.25	0.0	-0.05	-0.11		-0.26	-0.5	-0.73	0.26	0.58	-0.07	-0.87	0.85	0.84	-0.94	0.53	0.48	0.86
Intangible Assets	0.4	0.13	0.07	0.5	0.42	0.65	-0.41	0.02	0.56	0.4	0.49	0.14	-0.26		0.33	0.45	-0.05	-0.04	-0.12	0.25	-0.15	-0.13	0.38	-0.17	-0.03	-0.43
Common Stock	0.62	0.34	-0.18	0.83	0.64	-0.01	-0.83	0.05	0.2	0.76	0.71	0.62	-0.5	0.33		0.51	0.28	-0.04	-0.57	0.78	-0.33	-0.54	0.51	-0.27	-0.14	-0.4
Property Plant Equipment	0.06	0.13	-0.54	0.59	0.05	0.26	-0.3	-0.09	0.1	0.08	0.26	0.23	-0.73	0.45	0.51		0.12	-0.04	-0.19	0.68	-0.34	-0.71	0.76	0.02	-0.09	-0.63
Deferred Long Term Liab	0.63	0.85	0.03	0.29	0.59	-0.14	-0.39	-0.49	-0.53	0.19	0.36	0.78	0.26	-0.05	0.28	0.12		0.82	-0.51	-0.08	0.55	0.1	-0.26	0.7	0.47	0.23
Net Tangible Assets	0.51	0.83	0.41	0.01	0.46	0.07	-0.09	-0.7	-0.32	0.06	0.33	0.36	0.58	-0.04	-0.04	-0.04	0.82		-0.42	-0.47	0.84	0.39	-0.54	0.92	0.69	0.47
Long Term Debt Total	-0.81	-0.78	-0.3	-0.26	-0.79	-0.17	0.8	0.44	0.11	-0.56	-0.81	-0.57	-0.07	-0.12	-0.57	-0.19	-0.51	-0.42		-0.16	-0.36	0.15	0.14	-0.25	-0.02	-0.22
Capital Surpluse	0.11	-0.1	-0.62	0.71	0.13	-0.11	-0.5	0.35	0.19	0.4	0.25	0.33	-0.87	0.25	0.78	0.68	-0.08	-0.47	-0.16		-0.72	-0.79	0.89	-0.5	-0.51	-0.76
Long Term Investments	0.34	0.62	0.6	-0.41	0.3	0.11	0.11	-0.58	-0.37	0.02	0.14	0.08	0.85	-0.15	-0.33	-0.34	0.55	0.84	-0.36	-0.72		0.63	-0.79	0.8	0.54	0.73
Short Long Term Debt	0.06	0.11	0.74	-0.5	0.06	0.19	0.31	-0.31	0.0	-0.1	-0.09	-0.21	0.84	-0.13	-0.54	-0.71	0.1	0.39	0.15	-0.79	0.63		-0.72	0.34	0.35	0.59
Cash And Equivalents	-0.15	-0.29	-0.69	0.63	-0.13	0.12	-0.25	0.34	0.32	0.09	0.07	0.09	-0.94	0.38	0.51	0.76	-0.26	-0.54	0.14	0.89	-0.79	-0.72		-0.48	-0.45	-0.93
Net Invested Capital	0.23	0.69	0.29	-0.22	0.17	0.07	0.16	-0.7	-0.41	-0.21	0.07	0.16	0.53	-0.17	-0.27	0.02	0.7	0.92	-0.25	-0.5	0.8	0.34	-0.48		0.55	0.41
Capital Stock	0.17	0.31	0.31	0.07	0.15	-0.02	0.16	-0.52	-0.24	-0.16	0.13	0.2	0.48	-0.03	-0.14	-0.09	0.47	0.69	-0.02	-0.51	0.54	0.35	-0.45	0.55		0.4
Current Deferred Revenue	0.11	0.25	0.61	-0.62	0.09	-0.16	0.2	-0.37	-0.38	0.0	-0.06	-0.08	0.86	-0.43	-0.4	-0.63	0.23	0.47	-0.22	-0.76	0.73	0.59	-0.93	0.41	0.4

Click cells to compare fundamentals

MetLife EBITDA Historical Pattern

Today, most investors in MetLife Stock are looking for potential investment opportunities by analyzing not only static indicators but also various MetLife's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's ebitda growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of MetLife ebitda as a starting point in their analysis.

MetLife EBITDA

Timeline

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Competition

Predict MetLife

Ebitda Over Time

MetLife Ebitda

Ebitda

5.36 Billion

At this time, MetLife's EBITDA is comparatively stable compared to the past year.

According to the company disclosure, MetLife reported earnings before interest,tax, depreciation and amortization of 3.92 B. This is 93.8% lower than that of the Insurance sector and significantly higher than that of the Financials industry. This indicator is about the same for all United States stocks average (which is currently at 3.89850135491E9).

MetLife EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MetLife's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MetLife could also be used in its relative valuation, which is a method of valuing MetLife by comparing valuation metrics of similar companies.

MetLife is currently under evaluation in ebitda category among its peers.

MetLife ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, MetLife's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to MetLife's managers, analysts, and investors.

Environmental

Governance

Social

MetLife Institutional Holders

Institutional Holdings refers to the ownership stake in MetLife that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of MetLife's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing MetLife's value.

		Shares
Ameriprise Financial Inc	2024-06-30	7.9 M
Dimensional Fund Advisors, Inc.	2024-09-30	6.1 M
Northern Trust Corp	2024-09-30	6.1 M
Amvescap Plc.	2024-06-30	6 M
Bank Of America Corp	2024-06-30	5.9 M
Legal & General Group Plc	2024-06-30	5.3 M
Nuveen Asset Management, Llc	2024-06-30	5.2 M
Amundi	2024-06-30	4.6 M
Ubs Asset Mgmt Americas Inc	2024-09-30	4.5 M
Vanguard Group Inc	2024-09-30	58.3 M
Dodge & Cox	2024-09-30	54.7 M

MetLife Fundamentals

	Return On Equity	0.13
	Return On Asset	0.0058
	Profit Margin	0.05 %
	Operating Margin	0.15 %
	Current Valuation	71.41 B
	Shares Outstanding	692.42 M
	Shares Owned By Insiders	16.41 %
	Shares Owned By Institutions	75.48 %
	Number Of Shares Shorted	5.81 M
	Price To Earning	28.61 X
	Price To Book	1.85 X
	Price To Sales	0.83 X
	Revenue	66.9 B
	Gross Profit	14.89 B
	EBITDA	3.92 B
	Net Income	1.6 B
	Cash And Equivalents	20.2 B
	Cash Per Share	41.28 X
	Total Debt	18.83 B
	Debt To Equity	4.11 %
	Current Ratio	1.11 X
	Book Value Per Share	44.52 X
	Cash Flow From Operations	13.72 B
	Short Ratio	2.05 X
	Earnings Per Share	4.93 X
	Price To Earnings To Growth	0.14 X
	Target Price	91.46
	Number Of Employees	45 K
	Beta	1.04
	Market Capitalization	58.99 B
	Total Asset	687.58 B
	Retained Earnings	40.15 B
	Annual Yield	0.03 %
	Five Year Return	3.58 %
	Net Asset	687.58 B
	Last Dividend Paid	2.13

About MetLife Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze MetLife's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MetLife using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MetLife based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for MetLife Stock Analysis

When running MetLife's price analysis, check to measure MetLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetLife is operating at the current time. Most of MetLife's value examination focuses on studying past and present price action to predict the probability of MetLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetLife's price. Additionally, you may evaluate how the addition of MetLife to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC